title: [What is the role of hormonal treatments in acne?].
authors.affiliation: Service de gynécologie, Hôpital Edouard Herriot, 69437 Lyon.
authors.forename: E
authors.initials: E
authors.lastname: Drapier-Faure
authors.forename: M
authors.initials: M
authors.lastname: Faure
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy* / Q000209:etiology; D000726:Androgen Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D003534:Cyproterone / Q000494:pharmacology / Q000627:therapeutic use; D004967:Estrogens / Q000494:pharmacology / Q000627:therapeutic use*; D005485:Flutamide / Q000494:pharmacology / Q000627:therapeutic use; D005938:Glucocorticoids / Q000494:pharmacology / Q000627:therapeutic use*; D006727:Hormone Antagonists / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D009277:Nandrolone / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D018579:Patient Selection; D011372:Progestins / Q000494:pharmacology / Q000627:therapeutic use*; D013148:Spironolactone / Q000494:pharmacology / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000726:Androgen Antagonists; D004967:Estrogens; D005938:Glucocorticoids; D006727:Hormone Antagonists; D000451:Mineralocorticoid Receptor Antagonists; D011372:Progestins; D013148:Spironolactone; C023635:dienogest; D009277:Nandrolone; D005485:Flutamide; D003534:Cyproterone